Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham J Mann

Showing results (51-60 of 183) with videos related to

Pageof 19
Sort By:
Neoplasia (New York, N.Y.)|October 28, 2008
p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumorsStuart J Gallagher, John F Thompson, James Indsto, et al.
JAMA Dermatology|December 1, 2017
Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage MelanomaMbathio Dieng, Nadine A Kasparian, Anne E Cust, et al.
Pigment Cell & Melanoma Research|December 27, 2016
Mutation load in melanoma is affected by MC1R genotypePeter A Johansson, Antonia L Pritchard, Ann-Marie Patch, et al.
Applied Health Economics and Health Policy|June 23, 2019
Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage MelanomaMbathio Dieng, Nikita Khanna, Nadine A Kasparian, et al.
Genes, Chromosomes & Cancer|March 12, 2005
Intronic sequence variants of the CDKN2A gene in melanoma pedigreesMark Harland, Claire F Taylor, Sylvia Bass, et al.
Genes, Chromosomes & Cancer|September 4, 2010
Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case familiesRosemary L Balleine, Pamela J Provan, Gulietta M Pupo, et al.
Familial Cancer|September 29, 2020
FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanomaElizabeth A Holland, Serigne Lo, Blake Kelly, et al.
JAMA Dermatology|June 27, 2014
Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up studyFergal J Moloney, Pascale Guitera, Elliot Coates, et al.
Patient Education and Counseling|June 29, 2010
Development and pilot testing of an online screening decision aid for men with a family history of prostate cancerClaire E Wakefield, Kaaren J Watts, Bettina Meiser, et al.
JAMA Dermatology|November 10, 2016
Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based StudyCaroline G Watts, Christine Madronio, Rachael L Morton, et al.
Pageof 19

Showing results (51-60 of 183) with videos related to

Sort By:
Pageof 19
Neoplasia (New York, N.Y.)|October 28, 2008
p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumorsStuart J Gallagher, John F Thompson, James Indsto, et al.
JAMA Dermatology|December 1, 2017
Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage MelanomaMbathio Dieng, Nadine A Kasparian, Anne E Cust, et al.
Pigment Cell & Melanoma Research|December 27, 2016
Mutation load in melanoma is affected by MC1R genotypePeter A Johansson, Antonia L Pritchard, Ann-Marie Patch, et al.
Applied Health Economics and Health Policy|June 23, 2019
Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage MelanomaMbathio Dieng, Nikita Khanna, Nadine A Kasparian, et al.
Genes, Chromosomes & Cancer|March 12, 2005
Intronic sequence variants of the CDKN2A gene in melanoma pedigreesMark Harland, Claire F Taylor, Sylvia Bass, et al.
Genes, Chromosomes & Cancer|September 4, 2010
Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case familiesRosemary L Balleine, Pamela J Provan, Gulietta M Pupo, et al.
Familial Cancer|September 29, 2020
FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanomaElizabeth A Holland, Serigne Lo, Blake Kelly, et al.
JAMA Dermatology|June 27, 2014
Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up studyFergal J Moloney, Pascale Guitera, Elliot Coates, et al.
Patient Education and Counseling|June 29, 2010
Development and pilot testing of an online screening decision aid for men with a family history of prostate cancerClaire E Wakefield, Kaaren J Watts, Bettina Meiser, et al.
JAMA Dermatology|November 10, 2016
Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based StudyCaroline G Watts, Christine Madronio, Rachael L Morton, et al.
Pageof 19